title: Autoimmune Hemolytic Anemia.
abstract: Autoimmune hemolytic anemia is an acquired autoimmune disorder resulting in the production of antibodies directed against red blood cell antigens causing shortened erythrocyte survival. The disorders can present as a primary disorder (idiopathic) or secondary to other autoimmune disorders, malignancies, or infections. Treatment involves immune modulation with corticosteroids and other agents.
authors.affiliation: Jane Anne Nohl Division of Hematology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: liebman@usc.edu.
authors.forename: Howard A
authors.initials: HA
authors.lastname: Liebman
authors.affiliation: Jane Anne Nohl Division of Hematology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
authors.forename: Ilene C
authors.initials: IC
authors.lastname: Weitz
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D006403:Hematologic Tests; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D013156:Splenectomy
chemical_list: D007166:Immunosuppressive Agents
keywords: Anemia; Autoantibodies; Hemolysis